SILO PHARMA, INC. Other Receivables, Net, Current
SILO PHARMA, INC. (SILO) had Other Receivables, Net, Current of $60.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-24.
Discontinued › Notes › Receivables › and Others › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2023-03-24
- 2022-12-31: Other Receivables, Net, Current $60.00K.
- 2022-09-30: Other Receivables, Net, Current $60.00K.
- 2022-06-30: Other Receivables, Net, Current $60.00K.
- 2022-03-31: Other Receivables, Net, Current $60.00K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2022-12-31 | $60.00K 10-K · filed 2023-03-24 |
| 2022-09-30 | $60.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $60.00K 10-Q · filed 2022-08-01 |
| 2022-03-31 | $60.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $60.00K 10-K · filed 2023-03-24 |
| 2020-12-31 | $23.50K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |